加载中
NASDAQHealthcareBiotechnology
最新数据
US$4.74
−US$0.14 · -2.87%
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
常规交易时段
US$4.74
−US$0.14 · -2.87%
盘中时间采用ET。市场数据可能有所延迟。
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
日内区间
当前US$4.74
52周区间
当前US$4.74
盘中时间采用ET。市场数据可能有所延迟。
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
日内区间
当前US$4.74
52周区间
当前US$4.74
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|
| 营收 | — | — | — | 2.6万 USD |
| 销货成本 | — | — | — | 2.16万 USD |
| 毛利 | — | — | — | 4429 USD |
| 研究与开发 | 298.59万 USD | — | — | — |
| 销售、一般及管理费用 | 125.32万 USD | 29.04万 USD | 1.93万 USD | 2.47万 USD |
| 营业费用 | 423.91万 USD | 36.51万 USD | 1.93万 USD | 2.47万 USD |
| 利息支出 | 8537 USD | — | — | — |
| 折旧和摊销 | 7.94万 USD | — | 1815 USD | 2.12万 USD |
| 营业利润 | −423.91万 USD | −36.51万 USD | −1.93万 USD | −2.02万 USD |
| 净利润 | −422.51万 USD | −36.15万 USD | −1.92万 USD | −2.02万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2026年8月20日 | 1:20 | — | — |
已生效 2026年8月20日
1:20
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
